Skip to the page

Data / Form D filings / Gaingels Arda Therapeutics LLC

Gaingels Arda Therapeutics LLC: Form D filing

Gaingels Arda Therapeutics LLC, a company in Burlington, VT, filed a Form D with the SEC in 2024. The latest, on May 2, 2024, reports $97,500 sold of a $97,500 offering to 15 investors.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
C/O GAINGELS MANAGEMENT LLC, 3 MAIN STREET - SUITE 214, Burlington, VT, 05401
Phone
(773) 837-1889
Industry
Other
Entity type
Limited Liability Company
Incorporated in
Vermont
Year incorporated
2024
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2020505

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
May 2, 2024New notice$97,500$97,50015Apr 25, 2024sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
Paul GrossingerExecutive Officer

Other companies in Vermont that filed recently

Every Form D from the week of Apr 29, 2024 · All recent filings in Vermont · All recent Other filings

Read from SEC EDGAR. Amount sold is what Gaingels Arda Therapeutics LLC reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.